Active Ingredient: ROFLUMILAST
Proprietary Name: ZORYVE
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 0.15%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215985
Product Number: 002
Approval Date: Jul 9, 2024
Applicant Holder Full Name: ARCUTIS BIOTHERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
